Outer Biosciences utilizes a fully-integrated technology platform that combines ex vivo skin models with predictive machine learning to discover and develop novel bioactives for skin health. The company aims to provide safer and more effective compounds for health, skincare, and cosmetic applications, addressing the limitations of existing products in the market.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for discovering and developing bioactive compounds for skin health often rely on less predictive in vitro or in vivo models, leading to compounds with limited efficacy or safety concerns in human applications. Existing products may not adequately address complex skin conditions or provide optimal results for health, skincare, and cosmetic purposes.
Solution
Outer Biosciences employs a technology platform integrating ex vivo skin models with predictive machine learning to accelerate the discovery and development of novel bioactives. The platform utilizes complex, long-lasting, clinically-relevant ex vivo skin models to mimic human skin physiology. Multimodal data analysis and machine learning algorithms are applied to identify and validate compounds with improved efficacy and safety profiles. This approach enables the development of bioactives for health, skincare, and cosmetic products that outperform existing solutions.
Target Audience
The primary target audience includes companies in the health, skincare, and cosmetic industries seeking novel and effective bioactive compounds for product development.
Features
- Fully-integrated technology platform combining ex vivo skin models with predictive machine learning
- Clinically-relevant ex vivo skin models that mimic human skin physiology
- Multimodal data analysis for comprehensive compound characterization
- Predictive machine learning algorithms to identify and validate novel bioactives
- High-throughput screening capabilities for efficient compound discovery
- Advanced data analytics for identifying structure-activity relationships